Quoin Pharmaceuticals Ltd...

NASDAQ: QNRX · Real-Time Price · USD
7.50
0.20 (2.67%)
At close: Aug 15, 2025, 3:34 PM

Quoin Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
100.37K 100.37K 100.37K 154.77K 154.77K 154.77K 154.77K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
75.46K 74.85K 75.26K 101.21K 102.05K 102.85K 103.34K 103.33K 103.22K 103.21K 103.51K 103.7K 77.9K 110.44K 110.11K 83.98K 83.98K 25.74K
Gross Profit
-25.28K -24.67K -25.07K -101.21K -102.05K -102.85K -103.34K -103.33K -103.22K -103.21K -103.51K -103.7K -77.9K -110.44K -110.11K -83.98K -83.98K -25.74K
Operating Income
-12.76M -11.02M -9.52M -9.33M -8.92M -8.9M -9.26M -9.07M -9.27M -9.83M -9.19M -4.55M -3.54M -1.85M -1.06M -4.64M -3.67M -3.04M
Interest Income
505.98K 565.85K 558.49K 607.71K 657.75K 680.07K 694.61K 616.68K 435.39K 247.8K 95.75K 15.13K n/a n/a n/a n/a n/a n/a
Pretax Income
-12.25M -10.44M -8.96M -8.69M -8.27M -8.41M -8.69M -8.64M -9.74M -10.3M -9.38M -19.2M -17.57M -19.24M -21.46M -10.66M -9.59M -5.6M
Net Income
-12.17M -10.44M -8.98M -8.72M -8.3M -8.44M -8.47M -8.39M -10.21M -10.77M -9.58M -21.46B -21.46B -21.46B -21.47B -10.66M -9.59M -5.6M
Selling & General & Admin
6.02M 5.89M 5.94M 5.99M 6M 6.02M 6.07M 6.16M 6.37M 6.68M 6.58M 7.09M 6.55M 5.34M 4.5M 3M 2.26M 1.85M
Research & Development
6.67M 5.11M 3.56M 3.32M 2.91M 3.04M 3.31M 3.09M 3.08M 3.18M 2.67M 3.07M 2.58M 2.09M 1.56M 672.3K 438.31K 225.04K
Other Expenses
n/a n/a n/a -1.92K -1.92K -36.39K -15.96K -9.69K -12.74K 21.73K 78.54K 74.18K 77.24K -2.9M -3.47M -3.47M -3.47M -500K
Operating Expenses
12.68M 10.99M 9.5M 9.31M 8.91M 9.06M 9.38M 9.25M 9.45M 9.86M 9.26M 10.15M 9.13M 7.44M 6.06M 3.67M 2.7M 2.07M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a 714.08K 714.08K 714.08K 1.29M 822.3K 1.02M 1.09M 563.3K 315.13K 112.62K
Selling & Marketing Expenses
n/a -5.9K 12.02K 12.02K 12.02K 17.92K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
12.76M 11.02M 9.55M 9.36M 8.96M 9.09M 9.38M 9.25M 9.45M 9.86M 9.26M 10.15M 9.13M 7.44M 6.06M 3.67M 2.7M 2.07M
Income Tax Expense
-8.95B -8.95B -8.95B -8.95B 1.97M -187.59K -406.51K -432.52K 281.56K 469.15K 194.84K -7.47M -8.18M -8.18M -7.69M n/a n/a n/a
Shares Outstanding (Basic)
588.17K 586.33K 186.51K 5M 5.05M 2.1M 987.22K 987.22K 987.22K 987.22K 403.88K 274.37K 274.37K 55.91K 45K 20K 20K 20K
Shares Outstanding (Diluted)
588.17K 586.33K 186.51K 5M 5.05M 2.1M 987.22K 987.22K 987.22K 987.22K 403.88K 274.37K 274.37K 55.92K 45.2K 20.03K 20.03K 20.03K
EPS (Basic)
-41.6 -35.71 -30.33 -20.06 -5.56 -7.3 -8.6 -11.39 -23.08 -30.67 -49.53 -476.86K -476.91K -477.12K -477.29K -495.01 -441.21 -241.84
EPS (Diluted)
-41.64 -35.75 -30.37 -20.06 -5.56 -7.3 -8.6 -11.39 -23.08 -30.67 -49.52 -474.7K -474.76K -474.97K -475.14K -494.32 -440.62 -241.56
EBITDA
-12.56M -10.93M -9.43M -9.24M -8.63M -8.75M -9.07M -8.85M -9.24M -9.65M -9.05M -18.93M -17.91M -16.85M -18.48M -7.2M -6.22M -4.97M
EBIT
-12.66M -11.03M -9.53M -9.34M -8.73M -8.86M -9.17M -8.96M -9.35M -9.76M -9.16M -18.4M -17.24M -16.21M -17.84M -7.56M -6.74M -5.45M
Depreciation & Amortization
100.79K 100.18K 100.46K 100.93K 101.77K 102.57K 103.06K 103.33K 103.22K 103.21K 103.51K 103.7K 103.91K 136.45K 136.13K 136.01K 136.01K 103.77K